Cognitive functions affected by scopolamine in alzheimer's disease and normal aging
- 1 January 1988
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 12 (3-4) , 271-278
- https://doi.org/10.1002/ddr.430120310
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Glutamate dysfunction in Alzheimer's disease: an hypothesisTrends in Neurosciences, 1987
- Vasopressin in Alzheimer's disease: A study of postmortem brain concentrationsAnnals of Neurology, 1986
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Equivalent forms of the boston naming testJournal of Clinical and Experimental Neuropsychology, 1986
- Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementiaBehavioral and Neural Biology, 1986
- Neurochemical Studies of Early-Onset Alzheimer's DiseaseNew England Journal of Medicine, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Neurotransmitter-related enzymes in senile dementia of the alzheimer typeBrain Research, 1979
- Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brainsBrain Research, 1977
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976